Washington University School of Medicine
2,123
270
416
1,194
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.4%
391 terminated/withdrawn out of 2123 trials
75.3%
-11.2% vs industry average
7%
154 trials in Phase 3/4
53%
634 of 1194 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2123)
Transcutaneous Auricular Vagus Nerve Stimulation for Attenuation of Inflammatory Response and Blood Pressure in Type B Aortic Dissection
Role: lead
The Minimalist Trial-2
Role: lead
Brain Stimulation for Severe Depression
Role: collaborator
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Role: lead
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Role: lead
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
Role: lead
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
Role: collaborator
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Role: collaborator
Kidney Precision Medicine Project
Role: collaborator
BXCL501 After Stress to Increase Recovery Success
Role: collaborator
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
Role: lead
Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives
Role: lead
Testing the Impact of Family-Based Intervention to Improve Developmental and Health Outcomes for Female Adolescents
Role: collaborator
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Role: lead
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
Role: lead
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Role: lead
Neuroimaging of Parkinson's
Role: lead
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
Role: lead
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
Role: lead
Perioperative Mental Health in Orthopedic Surgery
Role: lead